Form 8-K Vanda Pharmaceuticals For: Oct 27
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
Vanda Pharmaceuticals (VNDA) Tops Q3 EPS by 35c
October 27, 2014 7:10 AM EDTVanda Pharmaceuticals (NASDAQ: VNDA) reported Q3 EPS of ($0.04), $0.35 better than the analyst estimate of ($0.39). Revenue for the quarter came in at $14.8 million versus the consensus estimate of $12.2 million.
For earnings history and earnings-related data on Vanda Pharmaceuticals (VNDA) click here.
... More